Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-27

Clinical Trial Update: Tedizolid Neuropathies

View source ↗

Summary

The completed trial update reports cases of optic and peripheral neuropathy in adults receiving tedizolid therapy, signaling a potential safety concern during t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sivextro (tedizolid)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Adult Patients Developing Optic or Peripheral Neuropathy, While Receiving Tedizolid Therapy Between July 2019 and December 2024 | Status: COMPLETED